Article
Alpha protein kinase 3 gene therapy restores heart function in mouse and human models of cardiomyopathy
19 Aug 2026
Abstract excerpt
. Here we establish an adeno-associated virus (AAV)-mediated gene replacement therapy to deliver full-length human ALPK3. AAV-ALPK3 prevented disease in neonatal Alpk3-mutant mice and reversed established pathology in adults, with proteomic analysis demonstrating reversal of more than 95% of the molecular disease signature. Beyond ALPK3 deficiency, we explored broader therapeutic potential based on ALPK3's...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
